Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08
Published July 12, 2023 · Recall initiated: June 26, 2023
Summary
FDA records drug Class II recall D-0895-2023, published July 12, 2023 and initiated June 26, 2023. Recalling firm: Strides Pharma Inc.; Status: Terminated; Reported quantity: 2,700 HDPE Bottles; Lot: Lot#: 7901903A, exp. date 04/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
What to do
Voluntary: Firm initiated · Letter
Get an email if LOSARTAN POTASSIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LOSARTAN POTASSIUM
- Manufacturer
- Strides Pharma Inc.
- Distributor
- Nationwide in the USA.
- UPC
- 0364380933052
- Lot
- Lot#: 7901903A, exp. date 04/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottlesJuly 12, 2023
- FDARomaine lettuce, packaged into the following configurations and sizes: 1. Medium, Produce Code 720832, 6-2lbJuly 12, 2023
- FDALosartan Potassium Tablets, USP 100 mg, 90 Tablets bottles, Rx Only, Marketed and Packaged By: PD-RxJuly 6, 2022
- FDALosartan Potassium Tablets, USP 25 mg, 90 Tablets bottles, Rx Only Marketed and Packaged By: PD-RxJuly 6, 2022
- FDALosartan Potassium Tablets, USP 50 mg, 90 Tablets bottles, Rx Only Marketed and Packaged By: PD-RxJuly 6, 2022
- FDALosartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, PlotJune 8, 2022
Questions about this recall
Was Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08 recalled?
Yes. FDA published recall D-0895-2023 on July 12, 2023. Reported hazard: Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LOSARTAN POTASSIUM. UPC: 0364380933052.